EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Evoq Remedies's Enterprise Value is ₹254.72 Mil.
Evoq Remedies's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was ₹93.67 Mil. Therefore, Evoq Remedies's EV-to-FCF for today is 2.72.
The historical rank and industry rank for Evoq Remedies's EV-to-FCF or its related term are showing as below:
BOM:543500'
s EV-to-FCF Range Over the Past 10 Years
Min: -7.22 Med: -5.33 Max: 2.72
Current: 2.72
During the past 5 years, the highest EV-to-FCF of Evoq Remedies was 2.72. The lowest was -7.22. And the median was -5.33.
BOM:543500's EV-to-FCF is ranked better than 80.65% of 62
companies
in the Medical Distribution industry
Industry Median: 15.59
vs BOM:543500: 2.72
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Evoq Remedies's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Evoq Remedies's EV-to-FCF
For the Medical Distribution subindustry, Evoq Remedies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evoq Remedies's EV-to-FCF Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Evoq Remedies's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Evoq Remedies's EV-to-FCF falls into.
Evoq Remedies EV-to-FCF Calculation
Evoq Remedies's EV-to-FCF for today is calculated as:
Evoq Remedies's current Enterprise Value is ₹254.72 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evoq Remedies's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was ₹93.67 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evoq Remedies (BOM:543500) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Evoq Remedies's PE Ratio for today is calculated as:
Evoq Remedies's share price for today is ₹9.74.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evoq Remedies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹1.006.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Evoq Remedies EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Evoq Remedies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:543500 has been successfully added to your